Genta Incorporated (GNTAQ)
-OTC Markets 0.00 0.00(0.00%) 11:50AM EDT
| Prev Close: | 0.00 |
|---|
| Open: | 0.00 |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | 0.63 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 0.00 - 0.00 |
|---|
| 52wk Range: | N/A |
|---|
| Volume: | 165,000 |
|---|
| Avg Vol (3m): | N/A |
|---|
| Market Cap: | 490.63K |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.08 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Genta: 1998-2012at TheStreet(Thu, Oct 25)
- GENTA INC DE/ FinancialsEDGAR Online Financials(Fri, Aug 10)
- GENTA INC DE/ Files SEC form 8-K, Other Events, Change in Directors or Principal OfficersEDGAR Online(Thu, Aug 2)
- GENTA INC DE/ Files SEC form 8-K, Other Events, Change in Directors or Principal OfficersEDGAR Online(Thu, Aug 2)
- GENTA INC DE/ Files SEC form 8-K, Other EventsEDGAR Online(Mon, Jul 30)
- GENTA INC DE/ Files SEC form 8-K, Non-Reliance on Previous Financials, Audits or Interim ReviewEDGAR Online(Fri, Jul 27)
- GENTA INC DE/ Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEDGAR Online(Thu, Jul 26)
- GENTA INC DE/ Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Mon, Jun 18)
- GENTA INC DE/ Files SEC form 8-K, Other EventsEDGAR Online(Fri, Jun 15)
- GENTA INC DE/ FinancialsEDGAR Online Financials(Fri, Jun 1)
- GENTA INC DE/ Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Thu, May 31)
- Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 4at Seeking Alpha(Sat, May 26)
- GENTA INC DE/ Files SEC form 8-K, Other EventsEDGAR Online(Fri, May 25)
- GENTA INC DE/ Files SEC form 8-K, Other EventsEDGAR Online(Fri, Apr 20)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 3.38 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(0-00-31)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Genta Incorporated, a biopharmaceutical company, engages in the identification, development, and commercialization of novel drugs for the treatment of cancer and related diseases.
View More 
0.06%